Odonate Therapeutics, Inc.

(No Reviews)
4747 Executive Dr Suite 510, San Diego, CA 92121, USA

Odonate Therapeutics, Inc. is located in San Diego County of California state. On the street of Executive Drive and street number is 4747. To communicate or ask something with the place, the Phone number is (858) 731-8180. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Odonate Therapeutics, Inc. quickly are 32.8750427 ,-117.2039142

Contact and Address

Address: 4747 Executive Dr Suite 510, San Diego, CA 92121, USA
Postal code: 92121
Phone: (858) 731-8180
Website: https://ir.odonate.com/contact-ir

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Odonate Therapeutics, Inc., use the form below and your opinion, advice or comment will appear in this space.

Write a Review


Odonate Therapeutics, Inc. On the Web

Odonate Therapeutics

Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. © 2019 Odonate Therapeutics, Inc.


Odonate Therapeutics, Inc. (ODT) Company Profile & Facts

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.


ODT Key Data - Odonate Therapeutics, Inc. | Seeking Alpha

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.


ODONATE THERAPEUTICS, INC. : Shareholders... | MarketScreener

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent.


Odonate Therapeutics Initiates CONTESSA TRIO | Business Wire

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend. Contacts. Odonate Therapeutics, Inc. John Lemkey Chief Operating Officer 858-731-8180 jlemkey@odonate.com.


NASDAQ:ODT - Odonate Therapeutics Stock Price, Forecast...

Odonate Therapeutics, Inc, a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer.


Highest paying jobs at Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. careers, pay and expert network. What are the highest paying jobs at Odonate Therapeutics, Inc.? Total value of jobs: $215,000.


Odonate Therapeutics, Inc. Common Stock (ODT) Latest... | Nasdaq

Find the latest quotes for (Odonate Therapeutics, Inc. Common Stock) (ODT) as well as charts and news at Nasdaq.com.


ODT Odonate Therapeutics Inc Current Report Filing (8-k)

Odonate Therapeutics, Inc. (Exact name of registrant as specified in its charter). 4747 Executive Drive, Suite 510. San Diego, CA 92121. (858) 731-8180. (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices).


Odonate Therapeutics to Present at the Cowen... — BioPortfolio.com

From BioPortfolio: Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and Printed From BioPortfolio.com. Odonate Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference.